For a number of viruses, oligomerization is a critical component of envelope processing and surface expression. Previously, we reported that a synthetic peptide (DP-107) corresponding to the putative leucine zipper region (aa 553-590) of the transmembrane protein (gp4l) of human immunodeficiency virus type 1 (HIV-1) exhibited a-helical secondary structure and self-associated as a coiled coil. In view of the tendency of this type of structure to mediate protein association, we speculated that this region of gp4l might play a role in HIV-1 envelope oligomerization. However, later it was shown that mutations which should disrupt the structural elements of this region of gp4l did not affect envelope processing, transport, or surface expression (assembly oligomerization). In this report we compare the effects of amino acid substitutions within this coiled-coil region on structure and function of both viral envelope proteins and the corresponding synthetic peptides. Our results establish a correlation between the destabilizing effects of amino acid substitutions on coiledcoil structure in the peptide model and phenotype of virus entry. These biological and physical biochemical studies do not support a role for the coiled-coil structure in mediating the assembly oligomerization of HIV-1 envelope but do imply that this region of gp4l plays a key role in the sequence of events associated with viral entry. We propose a functional role for the coiled-coil domain of HIV-1 gp4l.
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An essential component of human immunodeficiency virus type 1 (HIV-1) infection involves the interaction of the envelope glycoprotein (gpl20) with the CD4 protein expressed on the surface of the target cell (1) (2) (3) . However, with the exception of gpl20 shedding, processes which occur subsequent to CD4/gpl2O interaction but prior to membrane fusion remain poorly understood. The role of the transmembrane protein (gp4l) in this series ofevents has been the focus of a number of research efforts (4) (5) (6) (7) (8) (9) . Reports have described a leucine zipper-like (coiled-coil) motif located in the transmembrane protein of HIV-1 (10, 11) . This domain is highly conserved among HIV-1 isolates and analogous regions have been identified in the transmembrane proteins of a number of fusogenic viruses (11, 12 ). An alternating (heptad) repeat of ,-branched hydrophobic residues within the primary amino acid sequence is characteristic of this particular structure. Although the functional role of this structural motif in HIV-1 replication is yet to be established, studies in other systems suggest that leucine zipper regions serve as control elements by mediating protein multimerization (13) (14) (15) . Because oligomerization is an essential component of HIV-1 envelope processing, transport, and expression (16) (17) (18) , there has been speculation that a leucine zipper structure might play a role in this associative process (10, 11, 19) . Carr and Kim (20) reported that a pH-dependent conformational change which induces fusion in the influenza virus system includes formation of a coiled coil within the viral hemagglutinin and speculated that the leucine zipper-like domain of gp4l might serve a similar role in the HIV-1 system.
To define the function of this region of gp4l, we have used synthetic peptides and an envelope expression system. We found that a synthetic peptide corresponding to aa 553-590 of gp41 (DP-107) exhibits coiled-coil structure and accurately models the leucine zipper domain of the transmembrane protein. This peptide inhibits virus infection, and a strong correlation exists between peptide structure and antiviral activity (21) . We and others have found that mutations within this same region of the transmembrane protein, which should disrupt the coiled-coil structure, had no effect on synthesis, processing, transport, or surface expression of the HIV-1 envelope glycoprotein complex (22, 23) . While these changes did not affect assembly oligomerization, several of these mutations resulted in gpl20/gp4l constructs which were unable to support cell-cell fusion and infection (23, 24) .
Here we report the results of experiments with peptide analogs of the leucine zipper domain of gp4l which indicate that the ability of this region to assume stable coiled-coil structure is dramatically affected by substitutions at an invariant isoleucine residue (Ile573). Our studies with intact envelope indicate that while identical substitutions within this region have little or no effect on HIV-1 envelope (assembly) oligomerization, these structure disrupting changes greatly reduced or abrogated peptide antiviral activity and reduced or blocked envelope-mediated virus entry. These studies suggest that this region of gp4l does not play a major role in HIV-1 envelope oligomerization, that the role of the leucine zipper domain is related to the series of events associated with virus entry, and that the coiled coil within this region of gp4l is a critical component of this process.
MATERIALS AND METHODS
Peptide Synthesis and Circular Dichroism (CD). Peptides were synthesized, purified, and characterized as described (21) . CD spectra were measured at peptide concentrations of -10 ,M (21) determined from A280 (25) . Thermal denaturation experiments were carried out over a concentration range of 5-35 ,uM and the CD signal was monitored at 222 nm (21 Virus. The HIV-1LAI virus was propagated in CEM cells cultured in RPMI 1640/10% fetal bovine serum. Supernatant from infected cells was filtered and the infectious titer was estimated in a microinfectivity assay using the AA5 cell line to support virus replication (21 (23) . Cell surface expression of envelope was monitored with monoclonal antibody 9284 (DuPont), which is specific for the V3 loop of gp120 (23) .
Glycoprotein Oligomerization Analysis. Oligomerization analyses were as described previously except that cells were lysed with Triton buffer (23) . Precleared cell lysates were loaded onto 5-25% sucrose gradients and centrifuged for 18 hr at 40,000 rpm in a Beckman SW41 rotor at 4°C. Fourteen fractions were collected from each tube and immunoprecip- o itated with HIV-positive serum. Immune complexes were analyzed by SDS/8% PAGE. Cell Fusion and Infectivity Assays. Peptide inhibition experiments were performed as described (21) . In the infectivity assay, cells were tested for virus production at 6 days postinfection by measuring reverse transcriptase (RT) activity (see below), and the apparent infectious titer of the virus was calculated for each concentration ofpeptide. Multiplicity curves were generated by plotting the surviving virus fraction (VN/Vo) against peptide concentration (where VN is the infectious titer in the presence of peptide and VO is the titer in the absence of peptide). The micro-RT assay was adapted from Goff et al. (29) and Willey et al. (30) and was performed as described (21) . To determine the ability of envelope mutants to support fusion, HeLa-T4 cells were plated in 35-mm dishes (Costar) and transfected with 1 pg of pSRHP DNA. Two days after transfection, the cells were stained by the May-Grunwald/Giemsa technique (23) . RESULTS CD Studies of gp4l Peptides. We investigated the effect of substitutions at position 573 of the HIV-1 envelope coiledcoil domain on the structural stability of the peptides modeling this region (Fig. 1) . These experiments were carried out to establish a correlation between coiled-coil stability and the fusogenic potential of the corresponding HIV-1 envelope proteins.
The CD spectra for the WT and mutant peptides (Fig. 2 ) show the dramatic effect of single amino acid changes on coiled-coil structure. The mean residue ellipticities at 222 nm and 37°C for indicate that the WT peptide is a80% folded at this temperature whereas DP-140 (1573A) and DP-139 (I573S) are significantly less structured. DP-121 (1573P) had no discernible secondary structure. Thermal denaturation experiments were carried out to determine the stability of the mutant peptides compared with WT ( Table 1) . The DP-107 peptide (WT) at -35 ,uM exhibited extremely stable solution structure, with a Tm of 76°C. In contrast, DP-140 (I573A) and DP-139 (1573S) had Tm values of38°C and 22°C, respectively. As observed previously, DP-121 (I573P) exhibited no stable solution structure. The difference in stability for the alanine-substituted peptide compared with the WT sequence was observed over a broad concentration range (Fig. 2C) . The effect ofthe serine substitution was such that accurate Tm values could not be calculated at peptide concentrations < 35 ,uM (Fig. 2C) .
Inhibition of Virus-Mediated Cell-Cell Fusion and Virus Infection by gp4l Peptides. The WT gp4l peptide and the I573X mutants were assayed for their ability to inhibit virus fusion (Table 1) . DP-107 (WT) proved to be a potent inhibitor of cell-cell fusion (IC9o of 5 pg/ml). DP-140 (I573A) was substantially less active (IC90 of 17 pg/ml). DP-139 (1573S) gave a slight reduction in syncytium formation at 50 ug/ml -c 10 20 Wavelength (nm) tDue to the lack of observable solution structure, a Tm value (midpoint of the thermal denaturation curve) for the 1573P peptide (DP-121) could not be determined.
and DP-121 (I573P) exhibited no biological activity even at 100 ,g/ml. Similar results were obtained in experiments designed to determine inhibition of cell-free virus infection ( Table 1 ). In that assay DP-107 at 10 ,g/ml gave a 90% reduction in infectious virus titer, whereas the alanine mutant (DP-140) at 14 ,ug/ml gave a similar result. The serine (DP-139) and proline (DP-121) mutants exhibited no inhibitory activity at concentrations of up to 30 ,g/ml.
It is interesting to note the correlation between the intermediate antiviral activity of the alanine mutant (DP-140) and peptide solution structure. In Fig. 2A it is clear from both the positions and relative intensities of the characteristic double minima that although DP-140 exhibits less structure than the WT peptide, the structural components are predominately a-helical. Thus, DP-140 (1573A) efficiently models the coiledcoil region of gp4l but does not exhibit the same degree of overall stability as the WT peptide. This decreased stability results in the partial loss of antiviral activity. In contrast, Fig.  2A illustrates the direct disruptive effect that the serine (DP-139) and proline (DP-121) substitutions have on a-helical structure. Unlike the alanine mutant (DP-140) the spectra of these two peptides show much less evidence of secondary structure. This inability to model the secondary structural components results in peptides which do not block virus replication. We believe that it is this difference between destabilization of the coiled-coil structure and disruption of a-helical structural components that accounts for the observed differences in peptide antiviral activity.
Synthesis, Processing, and Assembly Oligomerization of the Mutant Envelope Proteins Occur Normally. To investigate the kinetics of transport and processing of envelope mutants, we carried out pulse-chase experiments using the alanine, serine, and proline mutants (Fig. 3) pSRHP-transfected COS-1 cells, equivalent levels of gp160 were immunoprecipitated from both WT and mutant glycoprotein-expressing cells (Fig. 3A) . During chases of 1, 2, and 4 hr, similar levels of cell-associated gpl20 were present in cells expressing WT protein as well as alanine and serine gp4l mutants. Immunoprecipitation of cell culture supernatants indicated that each of the proteins was transported to the cell membrane with similar kinetics (Fig. 3B) . In cells expressing the proline mutant, little cell-associated gpl20 was observed but higher levels of gpl20 could be immunoprecipitated from the culture supernatants, indicating that the cleaved products (gp4l and gp120) of this mutant precursor exhibited reduced association (Fig. 3B) .
To confirm that the proline substitution did not affect protein oligomerization, experiments were performed to directly assay this process. COS-1 cells were transfected with the pSRHP expression vector containing the WT or 1573P mutant env genes. Cells were either pulse labeled for 15 min or pulse labeled and chased for 3 hr. Cell lysates were run on 5-25% sucrose gradients (23) . After centrifugation, 14 fractions were collected, immunoprecipitated with HIV-positive serum, and analyzed by SDS/PAGE. The WT glycoprotein showed a distinct increase in sedimentation rate after the 3-hr chase, consistent with the formation of glycoprotein multimers; gp160 bands were immunoprecipitated from fractions further down the gradient than those in the pulse sample (Fig.  4) . Identical results were obtained with the I573P glycoprotein (Fig. 4) , with the exception of a small amount of gpl20 found in the chase gradient, indicating a rapid dissociation of gp120 following cleavage of the 1573P precursor.
Mutations Within the Leucine Zipper Region of gp4l Affect Fusogenic Potential but Not Cell Surface Expression. To determine the biological consequences of coiled-coil destabilizing mutations at aa 573 ofthe HIV-1 envelope, the ability ofmutant viral proteins to mediate virus entry was examined ( Fig. 5 ; Table 1 ). When the WT env vector was transfected into HeLa-T4 cells, syncytia containing 25-50 nuclei were observed after 48 hr (Fig. SA) . In contrast, none of the mutant envelope glycoproteins were able to induce WT syncytia. The I573A mutant glycoprotein exhibited an intermediate phenotype that was characterized by a reduced number of small syncytia that contained 3-7 nuclei (Fig. 5B) . The 1573S and 1573P mutations resulted in envelope complexes that were unable to support syncytium formation (Fig. 5 C and D) . Similarly, when the mutant env genes were substituted into the infectious proviral clone pHXB2D, the alanine substitution yielded a virus that was severely impaired in its ability to replicate whereas the serine mutation rendered the virus noninfectious ( expressed on the surface of the COS-1 cells transfected in parallel with the different vectors was unaffected by the mutations (Fig. 5 E-H) . These results support the conclusion that coiled-coil formation is critical to the fusogenic process but is unnecessary for oligomer assembly, transport, and surface expression.
DISCUSSION
Synthetic peptides can be used to model the coiled-coil structures present in a number of biological systems (32) . Our work with gp4l peptides indicates that aa 553-590 of the transmembrane protein of HIV-1 form a coiled-coil structure (21) . CD experiments illustrate the dramatic effect substitutions at the conserved isoleucine (I573X) can have on the stability of this structure. Dubay et al. (23) suggested that changes in envelope phenotype, which resulted from nonconservative amino acid substitutions at this position of the transmembrane protein (Ile to Ser or Glu), reflected how changes in hydrophobic character influenced protein function (23) . However, the data presented here indicate that these pheonotypic differences actually reflect the disruptive effect of these changes on coiled-coil structure.
Based on the effect of primary sequence substitutions in the peptide model, we expected that, if coiled-coil formation were the driving force in assembly oligomerization, analogous mutations in this region of the intact envelope protein would in some way alter this process. However, as shown here, both conservative and nonconservative changes at this position of the TM had no detectable effect on assembly oligomerization. Even after insertion of the helix-breaking proline residue, we were unable to detect any differences in the oligomeric state of the mutant and WT proteins. Hence, it seems unlikely that formation of coiled coil is critical for assembly oligomerization or for intracellular transport and surface expression.
In contrast, amino acid substitutions in this region of the HIV-1 transmembrane protein had a dramatic effect on the ability ofthe envelope glycoprotein to mediate virus entry. This defect in biological activity might be expected for the proline substitution, since stability of the gpl20/gp41 complex is reduced, but not for the serine-or alanine-substituted proteins. The effect these changes had on envelope function and the observation that only structured peptides modeling this region of gp4l inhibited virus replication lead us to conclude that the structural components found in this region of the transmembrane protein play a critical role in the events which culminate in virus entry. These observations have allowed us to develop a model which proposes a functional role for the coiled-coil region of gp4l as well as a mechanism by which peptides mimicking this domain inhibit virus infection.
For HIV-1 it has been established that following the interaction of gpl20 with CD4, the viral envelope undergoes conformational changes which expose previously inaccessible regions of gp4l (33) . Work by several groups (34, 35) indicates that one of these epitopes corresponds to the carboxyl terminus of the DP-107 sequence. We propose that prior to CD4 binding, the coiled-coil region of gp4l is constrained in a way that precludes its functional role in virus entry. However, once binding has occurred, conformational changes take place which cause residues 553-590 to undergo the transition from a monomeric, non-coiled-coil domain to a multimeric, coiled-coil structure (Fig. 6) . Our results indicate that coiled-coil formation is a critical component of virus entry and very likely mediates the formation of the fusogenic viral complex. A similar process has been proposed to take place within the HA2 protein of influenza virus (20) . While it is conceivable that envelope binding to the CD4 receptor alone might trigger the necessary conformational changes, it is likely that other biochemical processes are necessary. Further, we propose that it is during this entry event that the DP-107 peptide and its structural analogs exert their inhibitory effect and that this inhibition is related to the ability of the synthetic peptide to accurately mimic and interact (in a coiled-coil structure) with the complementary region of the virus transmembrane protein (Fig. 6) Although the specific function of the HIV-1 coiled-coil structure is unknown, several roles are possible. By analogy to influenza virus, coiled-coil formation might serve as a driving force to position the fusion domain of the transmembrane protein for insertion into the target cell membrane (20) . A second possible function involves the participation of the coiled-coil structure in the formation of a fusion pore. This dynamic event (initiated by insertion of the fusion peptide into the target cell membrane) may involve the continuous recruitment of subunit components (the coiled-coil dimer serving as a building block) until a functional fusion pore is formed (12, 35) . Amphipathic a-helical structures are known to function as membrane-spanning domains in a variety of systems (36) . A third scenario involves a combination of the roles described above, with coiled-coil formation serving as the driving force for insertion of the fusion peptide into the target cell membrane, with the resultant structure serving as a building block in formation of a fusion pore. The heptad repeat of hydrophobic amino acid residues which is predictive of coiled-coil structure has been observed in the surface proteins of a number of enveloped viruses (12, 19, 35, 37 
